Shigella vaccine breakthrough The live-attenuated oral Shigella sonnei vaccine WRSs2 reported 89% efficacy against shigellosis in a phase 2 controlled human infection trial — the highest protection rate ever recorded...
Download Infographic Overview Encourages individuals to assess their risk of exposure to a specific disease before deciding on vaccination. Explains how to weigh disease risks against vaccine risks and benefits. Defines...
WHO’s vaccination work represents one of the clearest examples of sustained, science‑based global cooperation in public health, and the attached summary illustrates how far‑reaching and internally coherent this effort...